Primary Recipient

LPATH THERAPEUTICS INC.

Amount

$3,000,000.00

Award Date

7/22/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Exudative (or wet) AMD (age-related macular degeneration) is the leading cause of severe vision loss and blindness among older Americans. While Lucentis-? and off-label use of Avastin-??the clear market leaders in wet AMD?improve vision in some patients f